Rolling the Dice on Bird Flu Stocks -- One Year Later
2926 views
Rate Now: 1 2 3 4

average rating: 4.00 / 1 ratings
Created by sarah z
DESCRIPTION:

Date updated:05-04-2007

From 10Q Detective

"In 2006, scientists fervently working on a treatment for H5N1, or bird flu, fearful that infected humans in China might be the start of a possible pandemic. This interest in experimental drugs and vaccines drew investors to any biotech stock that was remotely doing anything avian-related in nature. Sadly, like Tulipomania, dot-coms, and nanotechnology stocks, investors who ro! lled the dice on bird flu stocks—for the most part—have lost."

These are a few companies that may pay off big if the bird flue epidemic ever becomes a serious worldwide problem.

symbol name last price % change open
  • +
  • ENDP
    Endo Pharmaceutic
  • $22.20
  • -0.58%
  • $22.30

Symmetrel, FDA-approved to treat influenza A*

People owning ENDP also tend to own: HPCMCFSFLEGLF.OBNMXRMTAKAM

TheStreet.com Rating: B- What is this?

  • +
  • CARN
    Carn
  • $0.00
  • N/A
  • $N/A

Rec'd $6M grant from U.S. to develop H5N1 vaccine

People owning CARN also tend to own: GLWQQQQALNYAVANAVIIBCRXCBMX

TheStreet.com Rating: No Rating What is this?

  • +
  • DVAX
    Dynavax Technolog
  • $1.26
  • -2.33%
  • $1.27

Imunostimulatory sequence technology to target virus

People owning DVAX also tend to own: FNETMDVCATORCLACATBWNGEAG

TheStreet.com Rating: C- What is this?

  • +
  • VICL
    Vical Incorporate
  • $3.07
  • 0.00%
  • $N/A

Developing DNA-based vaccine vs. H5N1

People owning VICL also tend to own: AGTARIABQIDIETDVWENMDID

TheStreet.com Rating: D What is this?

  • +
  • AVAN
    Avan
  • $0.00
  • N/A
  • $N/A

Announced plans to research H5N1 vaccine

People owning AVAN also tend to own: ALGNCHINANUANTIBXVLNCICOSNE

TheStreet.com Rating: No Rating What is this?

  • +
  • AVII
    Avi Biopharma
  • $1.46
  • -5.81%
  • $1.54

Antisense-based therapeutic

People owning AVII also tend to own: FNSRRMIXADBEADMIVANNGASPEIX

TheStreet.com Rating: D- What is this?

  • +
  • CRXL
    Crucell Nv
  • $21.62
  • 0.00%
  • $N/A

PER.C6 tech used by Sanofi in H5N1 vaccine development

People owning CRXL also tend to own: AES-PCBACBMDGOOGPGHUNHAMX

TheStreet.com Rating: C What is this?

  • +
  • HEB
    Hemispherx Biopha
  • $1.02
  • 0.00%
  • $N/A

Alferon, stimulates Interferon to defend vs. H5N1

People owning HEB also tend to own: ATVICNEDISESLRHLYSHPQLVLT

TheStreet.com Rating: D- What is this?

previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...

11.23.09 | 10:34 AM
Cramer's Take on Headline Stocks...

Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...

11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...

11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...

11.19.09 | 11:13 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
huge rally in the making?
11.23.09 | 08:09 AM From author tradintrash
more forums
today 's lists
Biggest % Losers

Here is the stock list of some of the largest % losers from Nov. 20, 2009. more

TheStreet.com TV Videos

These are some of the stocks mentioned on TheStreet.com TV recently. Click the URL below each stock to watch the videos. more

Analyst Upgrades

Analyst Upgrades or Estimate Increases for Nov. 23, 2009. Read more here. more